In breast cancer, RNF181 prolongs the stability of ERa associated with AF1 via its RING domain binding to the domain of ERa, and enhancement of the gene expression of ERa promotes breast cancer progression (Zhu et al., 2020). This evidence concerns the gene RNF181 and breast cancer.